BioCryst Pharmaceuticals (NASDAQ:BCRX) Issues Earnings Results
BioCryst Pharmaceuticals (NASDAQ:BCRX – Get Free Report) released its quarterly earnings results on Monday. The biotechnology company reported ($0.07) EPS for the quarter, hitting analysts’ consensus estimates of ($0.07), Briefing.com reports. The firm had revenue of $117.10 million for the quarter, compared to analyst estimates of $113.99 million. During the same quarter last year, the […]
7 Nov 13:52 · The Markets Daily